Aktivne farmacevtske sestavine
Progestogen in estrogen | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Progesteron | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
Menenolon | Notranja |
Košer | 145-13-1 |
Medroxyprogesteron Acetat | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
Megerol acetat | CP/EP/USP | DMF v postopku | 595-33-5 |
Mifepriston | Cp/ip | DMF/GMP | 84371-65-3 |
Ciproteron acetat | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
Norethisterone |
CP/EP/USP/JP |
DMF v postopku |
68-22-4 |
Norethisterone acetat |
EP/USP |
DMF v postopku |
51-98-9 |
Norethisterone enanthat |
Notranja |
Pod raziskavo in razvoj |
3836-23-5 |
Drospirenon | EP/USP | DMF | 67392-87-4 |
Gestoden | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
Estriol | CP/EP/USP | Pod raziskavo in razvoj | 50-27–1 |
Etinilni estradiol | CP/EP/USP | GMP | 57-63-6 |
Estradiol valerat | CP/EP/USP/KP | DMF | 979-32-8 |
Estradiol cipionat |
USP | DMF v postopku |
313-06-4 |
Tubulon | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | Ep | CEP/GMP | 65928-58-7 |
Fulvestrant | EP/USP | Pod raziskavo in razvoj | 129453-61-8 |
Exemestane | CP/EP/USP | Pod raziskavo in razvoj | 107868-30-4 |
Androgen | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Finasterid | CP/EP/USP | CEP / FDA / PMDA / GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abirateron acetat | CP/USP | DMF/WC | 154229-18-2 |
Darolutami |
Notranja |
Pod raziskavo in razvoj |
1297538-32-9 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosteron undecanoat | Cp | DMF/WC | 5949-44-0 |
Testosteron cipionat | USP | Pod raziskavo in razvoj | 58-20-8 |
Testosteron enanthat |
USP/JP | Pod raziskavo in razvoj |
315-37-7 |
Testosteron propionat |
CP/EP/USP/JP |
Pod raziskavo in razvoj |
57-85-2 |
DHEA (praces) | Fp/Notranja | DMF/WC/Kosher | 53-43-0 |
Claskoteron | Notranja | DMF v postopku | 19608-29-8 |
Kortikalni hormon | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
Deson | CP/USP | DMF/GMP | 638-94-8 |
Eplerenone | Ep | CEP v postopku | 107724-20-9 |
Metilprednizolon | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
Metilprednizolon Hemisukcinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
Flutikazon propionat | CP/EP/USP | DMF | 80474- 14-2 |
Fluticazon bes | CP/EP | DMF v postopku | 397864-44-7 |
Mometasone furoate |
CP/EP/USP |
DMF v postopku |
Brezvodni (83919-23-7) Monohidrat (141646-00-6) |
Deflazakort |
Notranja |
Pod raziskavo in razvoj |
14484-47-0 |
Drugi | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Oxcarbazepin | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
Eslicarbazepin acetat | CP/USP | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hidroklorid | USP/EP | CEP v postopku | 175865-59-5 |
Osetamivir fosfat | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | Notranja | Pod raziskavo in razvoj | 1985606-14-1 |
Revefenacin | Notranja | DMF | 864750-70-9 |
Mirabegron | CP/EP | DMF | 223673-61-8 |
Vibegron |
Notranja |
Pod raziskavo in razvoj |
1190389-15-1 |
Escitalopram oksalat | CP/EP/USP | DMF v postopku | 219861-08-2 |
Citalopram hidrobromid |
CP/EP/USP |
DMF v postopku |
59729-32-7 |
Kariprazin hidroklorid | Notranja | DMF | 1083076-69-0 |
Lasmiditan Succinate | Notranja | DMF | 439239-92-6 |
Luliconazol | Notranja | DMF | 187164-19-8 |
Apalutami | Notranja | DMF | 956104-40-8 |
Tadalafil | CP/EP/USP | Pod raziskavo in razvoj | 171596-29-5 |
Replagolix | Notranja | DMF v postopku | 737789-87-6 |
Ruxolitinib fosfat |
Notranja |
DMF v postopku |
1092939-17-7 |
Abemaciclib |
Notranja |
Pod raziskavo in razvoj |
1231929-97-7 |
Phloroglucinol | CP/EP | DMF | 108-73-6 |
1,3,5-trimetoksibenzen |
CP/Inter |
GMP |
621-23-8 |
Ursodeoksiholična kislina | EP/USP/JP | Pod raziskavo in razvoj | 128-13-2 |
Tauroursodeoksiholična kislina |
Notranja |
Pod raziskavo in razvoj |
14605-22-2 |
Holesterol |
CP/EP/USP/JP |
Pod raziskavo in razvoj |
57-88-5 |
Omega-3-kislinski etilni etri 90 |
EP/USP |
DMF v postopku |
—— |
Trigliceridi srednje verige |
CP/USP/EP |
DMF |
—— |
Benzalkonijev klorid |
USP/EP/JP |
CEP v postopku |
8001-54-5 |
Oljčno olje (za injiciranje) |
CP/USP/EP/JP |
DMF v postopku |
8001-25-0 |
Jajčni fosfolipidi (za injiciranje) |
CP/USP/EP |
DMF |
93685-90-6 |
Prigrizek |
Notranja |
DMF v postopku |
203787-91-1 |
Progesteron ima specifikacije EP, USP, CP, JP, IP in KP. Na voljo je CEP, odobril EU-GMP, FDA.
Finasterid ima specifikacije EP, USP, CP, IP, JP. Na voljo je CEP, odobril FDA, PMDA in GMP.
Budezonid ima specifikacije USP, EP. Odobreni CEP, GMP in FDA.
Dutasterid ima specifikacije EP, USP, CP, IP, JP. Na voljo sta CEP in FDA.
Desonide ima specifikacije USP in EP. DMF na voljo.
Metilprednizolon ima specifikacije USP, EP, IP, JP in KP. DMF in WC na voljo.